832
Views
28
CrossRef citations to date
0
Altmetric
REVIEW

Safety of hormone replacement therapy in gynaecological cancer survivors

, , , , &
Pages 321-325 | Published online: 20 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Y. Wen, H. Huang, H. Huang, M. Wu, K. Shen & L. Pan. (2013) The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China. Climacteric 16:6, pages 673-681.
Read now
F. Guidozzi. (2013) Estrogen therapy in gynecological cancer survivors. Climacteric 16:6, pages 611-617.
Read now

Articles from other publishers (26)

Sung-Jin Kim & Hyunjeong Shin. (2023) The Experience of Gynecologic Cancer in Young Women: A Qualitative Study. Journal of Korean Academy of Nursing 53:1, pages 115.
Crossref
Kristy K. Ward, Alexandra Walker & Amy R. Carroll. 2023. Handbook of Gynecology. Handbook of Gynecology 1153 1168 .
Eshwarya Jessy Kaur, Upasana Baruah, Amita Maheshwari & Amal Chandra Kataki. 2022. Fundamentals in Gynaecologic Malignancy. Fundamentals in Gynaecologic Malignancy 429 438 .
Hasan Çilgin. 2020. Hormone Therapy and Replacement in Cancer and Aging-related Diseases. Hormone Therapy and Replacement in Cancer and Aging-related Diseases.
Nungrutai Saeaib, Krantarat Peeyananjarassri, Tippawan Liabsuetrakul, Rakchai Buhachat & Eva Myriokefalitaki. (2020) Hormone replacement therapy after surgery for epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2020:1.
Crossref
Sa Ra LeeMoon Kyoung ChoYeon Jean ChoSungwook ChunSeung-Hwa HongKyu Ri HwangGyun-Ho JeonJong Kil JooSeul Ki KimDong Ock LeeDong-Yun LeeEun Sil LeeJae Yen SongKyong Wook YiBo Hyon YunJung-Ho ShinHee Dong Chae & Tak Kim. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:2, pages 69.
Crossref
Prashant Purohit, Jennifer Sassarini & Mary Ann Lumsden. (2019) Management of Induced Menopause in Gynaecological Cancers and Their Challenges. Current Obstetrics and Gynecology Reports 8:3, pages 94-102.
Crossref
Marie Smith, Lorna Lightbody, Ali Allen & Michelle Winser. 2019. Nursing Management of Women’s Health. Nursing Management of Women’s Health 169 192 .
. (2018) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 25:11, pages 1362-1387.
Crossref
Roberto Angioli, Daniela Luvero, Grazia Armento, Stella Capriglione, Francesco Plotti, Giuseppe Scaletta, Salvatore Lopez, Roberto Montera, Alessandra Gatti, Giovan Battista Serra, Pierluigi Benedetti Panici & Corrado Terranova. (2018) Hormone replacement therapy in cancer survivors: Utopia?. Critical Reviews in Oncology/Hematology 124, pages 51-60.
Crossref
Margaret Whicker, Jonathan Black, Gary Altwerger, Gulden Menderes, Jacqueline Feinberg & Elena Ratner. (2017) Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer. American Journal of Obstetrics and Gynecology 217:4, pages 395-403.
Crossref
Chia-Chun Li, Yun-Fang Tsai, Ting-Chang Chang & Lynn Chen. (2017) Associations among menopausal symptoms, sleep and fatigue in Taiwanese women with endometrial cancer. European Journal of Cancer Care 26:5, pages e12559.
Crossref
. (2017) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24:7, pages 728-753.
Crossref
Nungrutai Saeaib, Krantarat Peeyananjarassri, Tippawan Liabsuetrakul, Rakchai Buhachat & Eva Myriokefalitaki. (2017) Hormone replacement therapy after surgery for epithelial ovarian cancer. Cochrane Database of Systematic Reviews.
Crossref
Susanne Schüler-Toprak, Stephan Seitz & Olaf Ortmann. (2017) Hormones and risk of breast and gynecological cancerHormone und das Risiko für Brustkrebs und gynäkologische Malignome. Der Gynäkologe 50:1, pages 43-54.
Crossref
Kristy Ward, Alexandra Walker & Amy R. Carroll. 2017. Handbook of Gynecology. Handbook of Gynecology 991 1006 .
Jing Chen, Rui Wang, Bo Zhang, Xingguang Lin, Juncheng Wei, Yao Jia, Ye Yin, Shuangmei Ye, Tao Zhu, Gang Chen, Yongxun Yuan, Weiguo Lu & Kezhen Li. (2016) Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis. American Journal of Obstetrics and Gynecology 215:4, pages 460.e1-460.e13.
Crossref
Sindhu S. Jacob, S. P. Somashekhar & Sean S. Jacob. (2016) Role of Hormone Replacement Therapy (HRT) in Gynecological Cancers: Endocrinologist’s Perspective. Indian Journal of Gynecologic Oncology 14:3.
Crossref
Rachel Louise O’Donnell, Katherine M. Clement & Richard J. Edmondson. (2016) Hormone replacement therapy after treatment for a gynaecological malignancy. Current Opinion in Obstetrics & Gynecology 28:1, pages 32-41.
Crossref
Kristy Ward, Alexandra Walker & Amy R. Carroll. 2016. Handbook of Gynecology. Handbook of Gynecology 1 16 .
Stephanie S. FaubionKathy L. MacLaughlinMargaret E. LongSandhya PruthiPetra M. Casey. (2015) Surveillance and Care of the Gynecologic Cancer Survivor. Journal of Women's Health 24:11, pages 899-906.
Crossref
Dong Li, Cheng-yi Ding & Li-hua Qiu. (2015) Postoperative hormone replacement therapy for epithelial ovarian cancer patients: A systematic review and meta-analysis. Gynecologic Oncology 139:2, pages 355-362.
Crossref
Åsa Hallqvist Everhov, Tommy Nyberg, Karin Bergmark, Anna Citarella, Angelique Flöter Rådestad, Angelica Lindén Hirschberg & Karin E. Smedby. (2015) Hormone therapy after uterine cervical cancer treatment. Menopause 22:6, pages 633-639.
Crossref
O. Ortmann, C. Lattrich & S. Buchholz. (2014) Klimakterische Symptome bei Frauen nach Therapie von hormonabhängigen KrebserkrankungenClimacteric symptoms in women after therapy of hormone-dependent cancer. Forum 29:3, pages 218-221.
Crossref
Rosemary Cochrane, Ailsa E Gebbie & Graeme Walker. (2013) Management of menopausal symptoms after cancer and risk-reduction bilateral oophorectomy: a move towards consensus. Menopause International 19:1, pages 30-36.
Crossref
Wen-Ling Lee, Fa-Kung Lee, Wen-Hsiang Su, Kuan-Hao Tsui, Cheng-Deng Kuo, Shie-Liang Edmond Hsieh & Peng-Hui Wang. (2012) Hormone therapy for younger patients with endometrial cancer. Taiwanese Journal of Obstetrics and Gynecology 51:4, pages 495-505.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.